leucine has been researched along with Cognition Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshordel, S; Eckert, GP; Igbavboa, U; Muller, WE; Wood, WG | 1 |
| Abbamondi, N; Anfossi, M; Bernardi, L; Bruni, AC; Bugiani, O; Clodomiro, A; Colao, R; Curcio, SA; Di Lorenzo, R; Foncin, JF; Forloni, G; Frangipane, F; Gallo, M; Geracitano, S; Giaccone, G; Leotta, A; Lio, SG; Maletta, R; Milan, G; Mirabelli, M; Muraca, MG; Nee, L; Pappatà , S; Pinessi, L; Postiglione, A; Puccio, G; Rainero, I; Rogaeva, E; Rubino, E; Smirne, N; Sorbi, S; Spillantini, MG; St George Hyslop, P; Terni, B; Tomaino, C | 1 |
| Borghgraef, P; Demedts, D; Devijver, H; Kremer, A; Maurin, H; Van Leuven, F | 1 |
| Browne, SM; Halligan, PW; Taggart, DP; Wade, DT | 1 |
| Helbling, C; Hoffmann, B; Schadewaldt, P; Wendel, U | 1 |
| Epstein, LG; Kieburtz, K; Marder, K; McArthur, JC; McDermott, MP; Sacktor, N; Schifitto, G; Small, S | 1 |
3 trial(s) available for leucine and Cognition Disorders
| Article | Year |
|---|---|
Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist.
Topics: Cognition Disorders; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Imidazoles; Leucine; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Platelet Activating Factor | 2003 |
Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.
Topics: Child; Cognition Disorders; Female; Humans; Intelligence Tests; Leucine; Male; Maple Syrup Urine Disease | 2006 |
Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.
Topics: Adult; Cognition Disorders; Double-Blind Method; Female; HIV; Humans; Imidazoles; Leucine; Male; Middle Aged; Neuropsychological Tests; Platelet Activating Factor | 1999 |
3 other study(ies) available for leucine and Cognition Disorders
| Article | Year |
|---|---|
Impaired geranylgeranyltransferase-I regulation reduces membrane-associated Rho protein levels in aged mouse brain.
Topics: Aging; Alkyl and Aryl Transferases; Animals; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cerebrum; Cognition Disorders; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Leucine; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Naphthalenes; Nerve Tissue Proteins; Neuroblastoma; Protein Prenylation; rab GTP-Binding Proteins; rac1 GTP-Binding Protein; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; RNA, Messenger; Synaptic Membranes; Synaptic Transmission; Terpenes | 2014 |
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.
Topics: Adult; Alzheimer Disease; Brain; Cognition Disorders; Family Health; Female; Fluorodeoxyglucose F18; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Global Health; History, 17th Century; History, 21st Century; Humans; International Cooperation; Italy; Leucine; Male; Memory Disorders; Methionine; Middle Aged; Mutation; Phenotype; Positron-Emission Tomography; Presenilin-1 | 2010 |
Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.
Topics: Age Factors; Animals; Bacterial Proteins; Brain; Cells, Cultured; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Female; Humans; Leucine; Luminescent Proteins; Male; Mice; Mice, Transgenic; Neurons; Phosphorylation; Proline; Synaptosomes; tau Proteins | 2011 |